Therapeutic Effect of Combination Therapy with Rituximab and Intravenous Immunoglobulin on the Progression of Chronic Antibody Mediated Rejection

• Main Authors: Yaeni Kim (Author), Yu Ah Hong (Author), Byung Ha Chung (Author), Bum Soon Choi (Author), Cheol Whee Park (Author), Yeong Jin Choi (Author), Yong-Soo Kim (Author), Chul Woo Yang (Author)
• Format: Book
• Published: The Korean Society of Nephrology, 2014-06-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

While combination therapy of Rituximab (RTX) and intravenous immunoglobulin (IVIg) (RIT) has been proposed as therapeutic strategy for the treatment of chronic active antibody-mediated rejection (CAMR), its efficacy has not been established. In this study, we compared clinical outcome between the tr...